XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities
9 Months Ended
Sep. 30, 2021
Debt Securities, Available-for-sale, Sale [Abstract]  
Marketable Securities Marketable SecuritiesRambus invests its excess cash and cash equivalents primarily in U.S. government-sponsored obligations, commercial paper, corporate notes and bonds, money market funds and municipal notes and bonds that mature within three years.
All cash equivalents and marketable securities are classified as available-for-sale. Total cash, cash equivalents and marketable securities are summarized as follows:
 As of September 30, 2021
(In thousands)Fair Value
Amortized
 Cost
Gross
 Unrealized
 Gains
Gross
 Unrealized
 Losses
Weighted
 Rate of
 Return
Money market funds$84,158 $84,158 $— $— 0.03 %
U.S. Government bonds and notes22,052 22,066 (16)0.27 %
Corporate notes, bonds and commercial paper245,805 245,934 23 (152)0.20 %
Total cash equivalents and marketable securities352,015 352,158 25 (168) 
Cash67,713 67,713 — —  
Total cash, cash equivalents and marketable securities$419,728 $419,871 $25 $(168) 
 As of December 31, 2020
(In thousands)Fair Value
Amortized
 Cost
Gross
 Unrealized
 Gains
Gross
 Unrealized
 Losses
Weighted
 Rate of
 Return
Money market funds$18,162 $18,162 $— $— 0.01 %
U.S. Government bonds and notes169,633 169,670 (40)0.12 %
Corporate notes, bonds and commercial paper253,391 253,412 61 (82)0.20 %
Total cash equivalents and marketable securities441,186 441,244 64 (122) 
Cash61,463 61,463 — —  
Total cash, cash equivalents and marketable securities$502,649 $502,707 $64 $(122) 
Available-for-sale securities are reported at fair value on the balance sheets and classified along with cash as follows:
As of
(In thousands)September 30, 2021December 31, 2020
Cash equivalents$84,158 $67,504 
Short-term marketable securities267,857 373,682 
Total cash equivalents and marketable securities352,015 441,186 
Cash67,713 61,463 
Total cash, cash equivalents and marketable securities$419,728 $502,649 
The Company continues to invest in highly rated and highly liquid debt securities. The Company holds all of its marketable securities as available-for-sale, marks them to market, and regularly reviews its portfolio to ensure adherence to its investment policy and to monitor individual investments for risk analysis, proper valuation, and unrealized losses that may be other than temporary.
The estimated fair value and gross unrealized losses of cash equivalents and marketable securities classified by the length of time that the securities have been in a continuous unrealized loss position at September 30, 2021 and December 31, 2020 are as follows:
 Fair ValueGross Unrealized Losses
(In thousands)September 30, 2021December 31, 2020September 30, 2021December 31, 2020
Less than 12 months    
U.S. Government bonds and notes$18,078 $70,548 $(16)$(40)
Corporate notes, bonds and commercial paper150,870 181,349 (152)(82)
Total cash equivalents and marketable securities in a continuous unrealized loss position$168,948 $251,897 $(168)$(122)
The gross unrealized losses at September 30, 2021 and December 31, 2020 were not material in relation to the Company’s total available-for-sale portfolio. The gross unrealized losses can be primarily attributed to a combination of market conditions as well as the demand for and duration of the U.S. government-sponsored obligations and corporate notes and bonds. The Company reasonably believes that there is no need to sell these investments and that it can recover the amortized cost of these investments. The Company has found no evidence of impairment due to credit losses in its portfolio. Therefore, these
unrealized losses were recorded in other comprehensive income (loss). However, the Company cannot provide any assurance that its portfolio of cash, cash equivalents and marketable securities will not be impacted by adverse conditions in the financial markets, which may require the Company in the future to record an impairment charge for credit losses which could adversely impact its financial results.
The contractual maturities of cash equivalents (excluding money market funds which have no maturity) and marketable securities are summarized as follows:
(In thousands)September 30, 2021
Due less than one year$164,232 
Due from one year through three years103,625 
Total$267,857 
Refer to Note 8, “Fair Value of Financial Instruments,” for discussion regarding the fair value of the Company’s cash equivalents and marketable securities.